Biological Variation Estimates for Plasma Copeptin and Clinical Implications
The Journal of Applied Laboratory Medicine · 2024
DOI: 10.1093/jalm/jfae005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2024. Verfasst von Kay Weng Choy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Northern Health, Epping, Australia. Hauptthemen laut MEDLINE: Glycopeptides, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Plasma copeptin measurement is useful for the differential diagnoses of polyuria-polydipsia syndrome. It has also been proposed as a prognostic marker for cardiovascular diseases. However, limited information is available about the within- (CVI) and between-subject (CVG) biological variation (BV). This study presents BV estimates for copeptin in healthy individuals.
Methods
Samples were collected weekly from 41 healthy subjects over 5 weeks and analyzed using the BRAHMS Copeptin proAVP KRYPTOR assay after at least 8 h of food and fluid abstinence. Outlier detection, variance homogeneity, and trend analysis were performed followed by CV-ANOVA for BV and analytical variation (CVA) estimation with 95% confidence intervals. Reference change values (RCVs), index of individuality (II), and analytical performance specification (APS) were also calculated.
Results
The analysis included 178 results from 20 males and 202 values from 21 females. Copeptin concentrations were significantly higher in males than in females (mean 8.5 vs 5.2 pmol/L, P < 0.0001). CVI estimates were 18.0% (95% CI, 15.4%–21.6%) and 19.0% (95% CI, 16.4%–22.6%), for males and females, respectively; RCVs were −35% (decreasing value) and 54% (increasing value). There was marked individuality for copeptin. No result exceeded the diagnostic threshold (>21.4 pmol/L) for arginine vasopressin resistance.
Conclusions
The availability of BV data allows for refined APS and associated II, and RCVs applicable as aids in the serial monitoring of patients with specific diseases such as heart failure. The BV estimates are only applicable in subjects who abstained from oral intake due to the rapid and marked effects of fluids on copeptin physiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Northern Health, Epping, Australia.
- Laboratory Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Department of Laboratory Medicine, National University Hospital, Singapore.
- Department of Pathology, The University of Melbourne, Royal Melbourne Hospital, Parkville, Australia.
- Eastern Health Pathology, Eastern Health, Box Hill, Australia.
- Department of Biochemistry, Dorevitch Pathology, Heidelberg, Australia.
ORCID-Profile: Tze Ping Loh
Zitieren
APA
Choy, K. W., Carobene, A., Loh, T. P., Chiang, C., Wijeratne, N., Locatelli, M., Coskun, A., Cavusoglu, C., & Unsal, I. (2024). Biological Variation Estimates for Plasma Copeptin and Clinical Implications. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfae005
Vancouver
Choy KW, Carobene A, Loh TP, Chiang C, Wijeratne N, Locatelli M, et al. Biological Variation Estimates for Plasma Copeptin and Clinical Implications. The Journal of Applied Laboratory Medicine. 2024. doi:10.1093/jalm/jfae005
BibTeX
@article{Choy2024,
author = {Choy, Kay Weng and Carobene, Anna and Loh, Tze Ping and Chiang, Cherie and Wijeratne, Nilika and Locatelli, Massimo and Coskun, Abdurrahman and Cavusoglu, Coskun and Unsal, Ibrahim},
title = {Biological Variation Estimates for Plasma Copeptin and Clinical Implications},
journal = {The Journal of Applied Laboratory Medicine},
year = {2024},
doi = {10.1093/jalm/jfae005}
}
EUVIMED